Alnylam Pharmaceuticals Q1 Earnings Call Highlights
Summary
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported what executives described as a strong start to 2026, driven by continued momentum in its transthyretin (TTR) amyl...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.